Unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: A call to action

• Dan M. Cooper,
• Mark A. Rothstein,
• Alpesh Amin,
• Jan D. Hirsch,
• Emma Cooper

Affiliations

Dan M. Cooper

ORCiD

Department of Pediatrics, School of Medicine, Institute for Clinical and Translational Science, University of California at Irvine, Irvine, CA, USA

Mark A. Rothstein

University of California at Irvine, Institute for Clinical and Translational Science, Irvine, CA, USA

Alpesh Amin

Department of Medicine, School of Medicine, University of California at Irvine, Irvine, CA, USA

Jan D. Hirsch

School of Pharmacy and Pharmaceutical Sciences, University of California at Irvine, Irvine, CA, USA

Emma Cooper

Department of Psychiatry, School of Medicine, University of California at Irvine, Irvine, CA, USA